用非类固醇免疫抑制疗法治疗心脏沙尔科毒症
Kenichiro Suwa1, Yoshihisa Naruse1, Takeru Nabeta2
1Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
International journal of cardiology. Heart & vasculature
|August 14, 2024
概括
非类固醇免疫抑制疗法对对皮质类固醇无反应的心脏类固醇患者有潜力. 这项研究评估了临床结果,表明它可能是特定患者群体的可行选择.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 治疗心脏类 Sarcoidosis 仍然是一个挑战.
- 非类固醇免疫抑制疗法是一种潜在的,尽管尚未确立的治疗方法.
- 这项研究调查了它在日本患者的临床效用.
研究的目的:
- 评估使用非类固醇免疫抑制剂治疗心脏沙尔科毒症患者的临床结果.
- 评估添加非类固醇药物的安全性和有效性,以皮质类固醇治疗.
主要方法:
- 从512名患者中的26名接受非类固醇免疫抑制剂的患者的回顾性分析.
- 包括保留氧葡萄糖摄入量,皮质类固醇副作用或心律失常的患者.
- 评估的结果包括全因死亡,致命的腹腔失常事件 (FVAE) 和心力衰竭住院治疗.
主要成果:
- 由于各种原因添加了非类固醇药物 (甲托雷克萨特,环素,环胺,阿扎西奥普林),包括保留的FDG摄入量和类固醇副作用.
- 14名患者的皮质类固醇减少;7名患者的FDG摄入量减少.
- 临床事件发生在11名患者 (42.3%),包括死亡 (19.2%),FVAE (15.4%) 和心力衰竭住院 (19.2%).
结论:
- 非类固醇免疫抑制疗法可能是心脏沙尔科毒症患者的有益选择.
- 对于那些不能仅靠皮质类固醇稳定或经历副作用的人来说,可以考虑使用它.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
547
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
547
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
103
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
103
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K